Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a report issued on Saturday. The firm set a “hold” rating on the stock.

Retractable Technologies Trading Up 2.7 %

Shares of RVP stock opened at $0.64 on Friday. Retractable Technologies has a 52-week low of $0.56 and a 52-week high of $1.34. The company has a 50-day simple moving average of $0.67 and a two-hundred day simple moving average of $0.89. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The company has a market capitalization of $19.16 million, a price-to-earnings ratio of -1.19 and a beta of 1.98.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent quarter. Hedge funds and other institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.